Press Releases

Consideration of $0.43 Cdn per Common Share represents a premium of approximately 274%

Cardston, Alberta--(Newsfile Corp. - June 6, 2024) - American Creek Resources Ltd. (TSXV: AMK) ("American Creek" or the "Company"), announces that it has entered into a non-binding and arm's length letter of intent dated June 5, 2024 (the "LOI") with Cunningham Mining Ltd. ("Cunningham"), a private British Columbia corporation, to engage in due diligence and negotiations regarding the... (continue reading...)

400+ teachers from the Greater Philadelphia area have been honored with the prestigious Citadel Heart of Learning Award, selected from thousands of nominees.

EXTON, Pa., June 6, 2024 /PRNewswire/ -- Citadel Credit Union, a leading credit union serving the Greater Philadelphia area, has recognized 35 Greater Philadelphia teachers for going above and beyond and truly "building strength in education" as part of the company's Citadel Heart of Learning Awards program.... (continue reading...)

SAN FRANCISCO, June 6, 2024 /PRNewswire/ -- In a May 29, 2024 order, United States District Court Judge for the Northern District of California, Haywood S. Gilliam, Jr., in Grace v. Bay Area Real Estate Information Services, Inc., et al., 23-cv-06352, dismissed the plaintiff's first amended complaint against Bartko LLP client Bay Area Real Estate Information Services, Inc. (BAREIS). A PDF version of the Order can be accessed here.

As noted in a recent article in... (continue reading...)

NEW YORK and PHILADELPHIA and LOS ANGELES, June 6, 2024 /PRNewswire/ -- CRED iQ, the fastest growing platform in Commercial Real Estate ("CRE") finance, is excited to announce the addition of Nikki Kirk as Chief Client Officer. In this role, Kirk will oversee all client relationships and continue to build CRED iQ's Client Success team. She will also play a critical role in strategic opportunities for the company.

... (continue reading...)

• Presentation will describe how clofutriben modulates key biomarkers of prednisolone efficacy and toxicity in patients with polymyalgia rheumatica.
• Sparrow’s Chief Scientific Officer will describe new insights about glucocorticoid action on the 75th anniversary of glucocorticoid utilization for treatment of rheumatic diseases.

PORTLAND, Ore.--(BUSINESS WIRE)-- Sparrow Pharmaceuticals will present interim results from a Phase 2 clinical trial of its novel... (continue reading...)